Table II.
Screening Rates and Appropriate Treatment Rates
| Characteristic | Screening Rate (N=5031) |
Appropriate Treatment Rate (N=1711) |
|---|---|---|
| Age, y | ||
| 21–44 | 25.2 | 90.2 |
| 45–64 | 49.7 | 76.6 |
| 65–84 | 53.8 | 66.1 |
| Sex | ||
| Male | 40.0 | 74.4 |
| Female | 36.9 | 82.6 |
| Ethnicity | ||
| White | 42.4 | 77.7 |
| African American | 41.2 | 86.9 |
| Other | 23.8 | 63.2 |
| Missing | 30.9 | 80.1 |
| Diabetes | ||
| Yes | 59.3 | 61.1 |
| No | 35.9 | 82.3 |
| Cardiovascular disease | ||
| Yes | 59.9 | 52.6 |
| No | 36.7 | 81.8 |
| Pretreatment LDL-C, mg/dL | ||
| ≤130 | NA | 94.0 |
| 131–159 | NA | 61.8 |
| 160–189 | NA | 54.9 |
| ≥190 | NA | 65.2 |
| ATP III risk category | ||
| Low | NA | 96.3 |
| Intermediate | NA | 74.8 |
| High | NA | 56.0 |
Abbreviations: ATP III, Third Report of the Adult Treatment Panel National Cholesterol Education Program; LDL-C, low-density lipoprotein cholesterol; NA, not available. Values are expressed as percentages.